NCT07334990Not yet recruiting
Impact of a Hypnotic Recording on Artifacts in 4D CT in the Context of Stereotactic Body Radiation Therapy for Lung Cancer
Source: ClinicalTrials.gov · Last updated 12 Jan 2026
Brief summary (registry, in English)
This is a single-center prospective cohort study evaluating the impact of a simple audio recording hypnosis system on the occurrence of artifacts on 4D CT scans in patients requiring SBRT radiotherapy for lung lesions (peripheral or central). The primary objective of the study is to evaluate the use of a hypnotic recording on the reduction of artifacts in 4D CT scans for patients undergoing stereotactic body radiation therapy for lung cancer. The secondary objectives are to evaluate: * the impact of hypnotic recording on the reduction of artifacts on intrathoracic structures (trachea, main bronchi, diaphragm, lesions, heart, and lungs), * the regularity of respiratory amplitude, * the regularity of respiratory rate, * the volume of Internal Target Volume (ITV), * the reproducibility of ITV volume, * patient satisfaction. 1. Before this dosimetric scan, the patient will complete a self-administered questionnaire on anxiety: the HADS-A questionnaire (Hospital Anxiety and Depression Scale-only questions relating to anxiety). During this examination, the MERM explains the dosimetric scan procedure to the patient. After the immobilization system has been set up in accordance with the department's standard protocol, a 4D CT scan will be performed while asking the patient to breathe regularly. In the event of an artifact at the level of the lesion, a second 4D CT scan will be performed under the same conditions. 2. The hypnotic audio recording will be played through the room's speakers. The hypnotic recording is structured in three stages, with a 5-minute induction phase, a 5-minute working phase, and finally a 5-minute return phase. After 5 minutes of playback, the 4D CT scan for the study is performed using the same acquisition parameters as the free 4D CT scan. 3. Following the first radiotherapy session and for all patients included in the study, a 4D dosimetric scan will be performed using the hypnotic recording again, as described above, in order to assess the inter-fraction reproducibility of the ITV volume. Following this second 4D CT scan under hypnosis, patient satisfaction will be assessed (using a Likert scale questionnaire).
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- First submitted
- 16 Dec 2025
- Start date
- 30 Dec 2025
- Primary completion date
- 30 Jan 2027
- Lead sponsor
- Centre Leon Berard
- Diseases
- Lung cancer
- NCT number
- NCT07334990
What you commit to
- Study type: Interventional
- Planned participants: 25
- From 30 Dec 2025 to the primary completion date, 30 Jan 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Indication for treatment with abdominal compression,
Other illness
- Cognitive or physical disorders preventing the trial from proceeding smoothly,
- Patient with one or more active psychotic disorders (such as schizophrenia),
- Patients suffering from severe dissociative disorders,
Other
- Patient undergoing treatment for multiple lesions in the same treatment sequence,
- Patient with an ultra-central lesion (distance to the mediastinum \< 2 cm),
- Patient already included in this protocol,
- Patient who does not understand French or is deaf,
- Pregnant or breastfeeding women,
- Patient under guardianship or curatorship or deprived of liberty.
Who the study is looking for
- Age ≥18 years,
- Indication for lung SBRT, peripheral or central lesion,
- Patient new to hypnosis (medical or stage hypnosis),
- Patient covered by social security or equivalent,
- Dated and signed consent form.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.